Brainscape's Knowledge GenomeTM


Top Flashcards (Certified)
All Flashcards

CVR > Constituents Of Blood > Flashcards

Constituents Of Blood Flashcards

(116 cards)

Start Studying
1
Q

Anaemia

A

haemoglobin level in blood below the normal level for age and sex
• male <130g/L + female <110g/L

classified according to the size of the red cells into macrocytic, normocytic and microcytic
• The Reticulocyte count, morphology of the red cells and changes in the white cell and/or platelet count help diagnose anaemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Features of anaemia

A

shortness of breath on exertion, pallor of mucous membranes, malaise and angina in older people and tachycardia. Potentially also jaundice, leg ulcers

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Causes of anaemia

A

Corpuscular (mainly haemolysis):
• membrane (eg spherocytosis, PNH)
• Haemoglobin (eg haemoglobinopathy)
• Enzymes (eg G6PD, PK)
Extra-corpuscular:
• Production mismatches- hypoplastic (not enough), dyshaemotpoeitic (ineffective production)
• Increased removal of erythrocytes- acute blood loss (haemorrhage), haemolytic anaemia, auto or alloimmune, mechanical damage, other (eg heat, chemicals)
• Deficiencies of iron, folate (macrocytic anaemia) or vitamin B12 (pernicious)
• Redistribution- hypersplenism

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Classifying anaemia-hypoxia

A

Hypo regenerative (don’t produce red blood cells) vs hyper-regenerative (loading reed blood cells)
Reduced production vs increased destruction
Corpuscular (problem with cells) vs extra-corpuscular

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Haematocrit (PCV)

A

ratio of volume of red blood cells to total volume (45%)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Reticulocyte

A

final precursor to erythrocyte. Contains some rRNA and is able to synthesis haemoglobin. Circulates in the peripheral blood for 1-2 days before maturing

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Erythropoesis

A

regulated by the hormone erythropoietin (a heavily glycosylated polypeptide)- secreted by the kidney in response to hypoxia
• It stimulates Erythropoesis by increasing the number of progenitor cells
• Hypoxia induces synthesis of hypoxia-inducing factors (HIF-1 alpha and beta) which stimulate erythropoietin production and also new vessel formation and transferrin receptor synthesis, and reduces hepcidin synthesis, increasing iron absorption.
• Erythropoietin production increase in anaemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Erythrocytes

A

120 day lifespan
• 6-8um diameter
• Anuclear biconcave disc- flexible
• Contain haemoglobin and glycolytic enzymes
• Able to generate ATP by anaerobic glycolytic pathway
• Oxygen and carbon dioxide transport
• removed in spleen, liver, bone marrow (reticuloendothelial system) and through blood loss

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Haemoglobin

A

capable of reversibly binding to oxygen
• haemoglobin synthesis occurs largely in the mitochondria by a series of biochemical reactions commencing with the condensation of glycine and succinyl co-A under the action of the rate limiting enzyme aminolavulinic acid synthase (ALA)
• Protoporphyrin combines with iron in the ferrous state to form haem
• A tetramer of 4 globin chains each with its own haem group then form to make a haemoglobin molecule
• mutations or absence of alpha or beta chains in adults referred to as thalassemia (potentially causing anaemia)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Thalassemia

A

mutations or absence of alpha or beta chains in adults referred to as thalassemia (potentially causing anaemia)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

innate immunity

A

neutrophils, eosinophils, basophils, macrophages, mast cells- non-specific immunity (cytokines, phagocytosis, cytotoxicity)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Adaptive immunity

A

B cells, T cells- antigen-specific immunity (cytokines, antibodies, cytotoxicity)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Myelopoiesis

A

production of white blood cells, hormonal factor: granulocyte-macrophage colony stimulating factor (GM-CSF)- only stimulate production of myeloblastic white blood cells not lymphoid cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Neutrophils

A

phagocytotic and release chemo- and cytokines to induce inflammation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Monocytes function

A

mature into either macrophages or dendritic cells (both antigen presenting)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Basophils

A

mature into mast cells.
Express surface IgE and release histamine- role in allergies an immunity (anaphylaxis)
Stain blue

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Eosinophils function

A

Antagonistic to basophils: decrease mast cell histamine secretion
particular role in fighting parasitic infections but also wide range of regulatory functions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Where are Granulocytes produced

A

Made in the bone marrow under the control of a variet of growth factors and have a short lifespan in the blood stream before entering tissues

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Lymphocytes

A

immunologically competent white cells that are involved in antibody production (B cells) and with the body’s defence against viral infection or other foreign invasion (T cells)
• Arise from haemopoietic stem cells in the marrow- T cells processes in the thymus
Only blood cells that divide

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

B cells

A

secrete antibodies specific for individual antigens (M, A, G, E, D)
20% of lymphocytes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

T cells

A

further subdivided into helper (CD4+) and cytotoxic (CD8+) cells- they recognise peptides in HLA antigens
• Natural killer cells are cytotoxic CD8+ cells that kill target cells with low expression of HLA molecules
80% of lymphocytes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Immune response

A

occurs in the germinal centre of lymph node and involves B cell and T cell proliferation, somatic mutation, selection of cells by recognition of antigen on antigen-presenting cells and formation of plasma cells or memory B cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Plasma

A

fluid component of blood- 55%
• Transportation medium which contains water, salt, glucose and proteins

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Serum

A

Blood plasma without clotting factors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Cryoprecipitate
centrifuged blood plasma containing clotting factors and fibrinogen
26
Plasma proteins
• albumin: produced in the liver. Determines oncotic pressure of blood, keeps intravascular fluid within that space, lack of albumin leads to oedema, seen in liver disease and nephrotic syndrome ( loss of protein in urine) • carrier proteins • Coagulation proteins • Immunoglobulins- produced by activates B cells
27
Platelets
circulate in an inactive form • Anucleate cells- structure: plasma membrane, cytoskeleton, dense tubular system, secretory granules ( alpha, eg VWF, PF4, plasminogen; dense eg serotonine; lysosome; peroxisome) • 2-5um • Lifespan- 7-10 days
28
Where are platelets derived from
megakaryocytes- enter endomitosis where the chromosomes duplicate but the cells do not divide (polyploidy) • Membrane blebbing process- platelets break off from the megakaryocytes. 1 megakaryocyte can produce up to 4000 platelets • Stimulated by thrombopoietin
29
5 stages of platelet plug formation
1. Endothelial injury 2. Exposure 3. Adhesion 4. Activation 5. Aggregation
30
Endothelial injury
• smooth muscle cells and nerves detect injury • trigger reflexive contraction of vessel (vascular spasm)- reduces blood flow and loss • Secretion of nitric oxide and prostaglandins stop- secretion of endothelin begins → further contraction
31
Exposure
• damage to endothelial cells exposed collagen • Damaged cells release Von Willebrand factor (binds to collagen)
32
Adhesion
GP1B surface proteins on platelets bond to Von Willebrand factor
33
Activation
• platelet changes shape (smooth to spiculated, increasing their surface area), releases more Von Willebrand factor, serotonin, calcium, ADP, thromboxane A2 (positive feedback loop) • ADP and thromboxane A2 result in GPIIB/IIIA expression
34
Aggregation
GPIIB/IIIA binds to fibrinogen and links platelets → platelet plug
35
3 Anti-clotting systems
1. Tissue factor pathway inhibitor inhibits the tissue factor–factor VIIa complex. 2. Protein C, activated by thrombin, inactivates factors VIIIa and Va. 3. Antithrombin III inactivates thrombin and several other clotting factors.
36
Fibrinolytic system
Clots are dissolved by the fibrinolytic system. • A plasma proenzyme, plasminogen, is activated by plasminogen activators to plasmin, which digests fibrin. • Tissue plasminogen activator is secreted by endothelial cells and is activated by fibrin in a clot.
37
Anti-clotting drugs
• Aspirin inhibits platelet cyclooxygenase activity thereby inhibiting prostaglandin and thromboxane production—this inhibits platelet aggregation. • Oral anticoagulants and heparin interfere with clotting factors—they prevent clot formation. • Recombinant tissue plasminogen activator (t-PA) is a thrombolytic—it dissolves blood clots after they are formed.
38
Platelet plug formation
1. Injury to a vessel disrupts the endothelium and exposes the underlying connective-tissue collagen fibres. 2. Platelets adhere to collagen, largely via an intermediary called von Willebrand factor (vWF), a plasma protein secreted by endothelial cells and platelets. This protein binds to exposed collagen molecules, changes its conformation, and becomes able to bind platelets- vWF forms a bridge between the damaged vessel wall and the platelets 3. Binding of platelets to collagen triggers the platelets to release the contents of their secretory vesicles, which contain a variety of chemical agents. Many of these agents, including adenosine diphosphate (ADP) and serotonin, then act locally to induce multiple changes in the metabolism, shape, and surface proteins of the platelets, a process called platelet activation. Some of these changes cause new platelets to adhere to the old ones, a positive feedback phenomenon (platelet aggregation), which rapidly creates a platelet plug inside the vessel. 4. Chemical agents in the platelets’ secretory vesicles are not the only stimulators of platelet activation and aggregation. Adhesion of the platelets rapidly induces them to synthesize thromboxane A2, a member of the eicosanoid family, from arachidonic acid in the platelet plasma membrane. Thromboxane A2 is released into the extracellular fluid and acts locally to further stimulate platelet aggregation and release of their secretory vesicle contents
39
Platelet biochemistry
Activation → adhesion → aggregation → amplification pathways
40
Which clotting factor is tested for as part of a prothrombin time test
Factor VII as part of extrinsic clotting pathway
41
Blood coagulation: clot formation:
1. Blood is transformed into a solid gel when, at the site of vessel damage, plasma fibrinogen is converted into fibrin molecules, which then bind to each other to form a mesh. 2. This reaction is catalyzed by the enzyme thrombin, which also activates factor XIII, a plasma protein that stabilizes the fibrin meshwork. 3. The formation of thrombin from the plasma protein prothrombin is the end result of a cascade of reactions in which an inactive plasma protein is activated and then enzymatically activates the next protein in the series. • Thrombin exerts a positive feedback stimulation of the cascade by activating platelets and several clotting factors. • Activated platelets, which display platelet factor and binding sites for several activated plasma factors, are essential for the cascade. 4. In the body, the cascade usually begins via the extrinsic clotting pathway when tissue factor forms a complex with factor VIIa. This complex activates factor X, which then catalyzes the conversion of small amounts of prothrombin to thrombin. This thrombin then recruits the intrinsic pathway by activating factor XI and factor VIII, as well as platelets, and this pathway generates large amounts of thrombin. • The liver requires vitamin K for the normal production of prothrombin and other clotting factors.
42
Plasminogen
precursor for an enzyme that lyses clots
43
Anticlotting Systems:
1. Tissue factor pathway inhibitor inhibits the tissue factor–factor VIIa complex. 2. Protein C, activated by thrombin, inactivates factors VIIIa and Va. 3. Antithrombin III inactivates thrombin and several other clotting factors. • Clots are dissolved by the fibrinolytic system. • A plasma proenzyme, plasminogen, is activated by plasminogen activators to plasmin, which digests fibrin. • Tissue plasminogen activator is secreted by endothelial cells and is activated by fibrin in a clot.
44
Anticlotting drugs:
• Aspirin inhibits platelet cyclooxygenase activity thereby inhibiting prostaglandin and thromboxane production—this inhibits platelet aggregation. • Oral anticoagulants and heparin interfere with clotting factors—they prevent clot formation. • Recombinant tissue plasminogen activator (t-PA) is a thrombolytic—it dissolves blood clots after they are formed.
45
Clotting screen:
• PT- prothrombin time (activity of Factor VII) • APRT- activated partial thromboplastin time (activity of factor IX and factor XI) • Fibrinogen • Used to measure activity of medications eg warfarin which inhibits Factor VII, so increased PT/ heparin » elevated APRT • Used to show haemophilia A/B/C- raised APRT without elevated PT
46
Constituents the coagulation cascade:
A series of proteolytic enzymes that circulate in plasma in an inactive form and generate thrombin when activated
47
Functions of the liver
• responsible for synthesising coagulation factors and fibrinogen • Filtration of portal blood • Detoxification • Biliary drainage • Glucose regulation • Protein, amino acid, vitamin, fat synthesis and storage
48
Extrinsic coagulation pathway
damage to the endothelial lining of vessels releases tissue factor which activates factor VIIa. Factor VIIa has direct effect on factor Xa to initiate common part of cascade
49
Intrinsic coagulation cascade
blood contracting endothelial collagen outside the lumen activates factor XIIa (serum protease) → XIa → IXa. Factor Xa then activated by IXa along with cofactors VIII, phospholipids and Ca2+
50
Common pathway of coagulation cascade
Xa converts prothrombin (factor II) into thrombin (factor IIa) • Thrombin converts fibrinogen (I) into fibrin (Ia) and activates factor XIII - leading a the crosslinking of fibrin and a clot • Thrombin also gives positive feedback on factors V, VII, VIII and XI but also prevents over-coagulation by activating plasmin which is fibrinolytic
51
Order of clotting factors in intrinsic coagulation pathway
12 → 11 → 9 → 8 → 10
52
thrombin
fibrinogen is converted into fibrin molecules, which then bind to each other to form a mesh. This reaction is catalyzed by the enzyme thrombin, which also activates factor XIII, a plasma protein that stabilizes the fibrin meshwork.
53
Which vitamin is required by the liver for normal production of prothrombin and other clotting factors
Vitamin K
54
Platelet activation:
Shape change = • Smooth discoid → spiculated and pseudopodia • increases surface area • Increases possibility of cell-cell interactions Glycoprotein IIb/IIIa receptor = • on surface of platelet (50000-100000 copies on resting platelet) • Activation increase number of receptors and affinity of receptor for fibrinogen • Fibrinogen links receptors, binding platelets together (platelet aggregation) • Also known as integrin (alpha)IIb(beta)3 Release of alpha and dense granules
55
Why does the platelet plug not spread along the normal endothelium
the latter secretes prostacyclin and nitric oxide, both of which inhibit platelet aggregation.
56
COX-1
mediates GI mucosal integrity and thromboxane A2-mediated platelet aggregation (+ vasoconstriction)
57
COX-2
Mediates inflammation. Involved in prostacyclin production, which inhibits platelet aggregation and affects renal function
58
Arachidonic acid
converted into prostaglandins by COX (cyclooxygenase)
59
Platelet receptors
After atherosclerotic plaque rupture- platelets adhere to damaged vessel wall • Collagen receptors bind to subendothelial collagen which is exposed by endothelial damage • GPIIb/IIIa also binds to von Willebrand factor (VWF) which is attached to collagen • Soluble agonists are also released and activate platelets leading to shape change, cross-linking of GPIIB/IIIa and platelet aggregation • Aspirin inhibits an amplification pathway
60
Platelet purinergic receptors: ADP-induced platelet aggregation
• platelet P2Y receptors- different G proteins link to different signalling pathways ADP activates P2Y1 • Causes platelet activation • Results in GPIIb/IIIa fibrinogen cross-linking and aggregation ADP activates P2Y12 • amplification of platelet activation, aggregation and platelet dense granule release • Inhibits adenylate cyclase so drop in cAMP levels
61
ADP activates P2Y1
• Causes platelet activation • Results in GPIIb/IIIa fibrinogen cross-linking and aggregation
62
ADP activates P2Y12
• amplification of platelet activation, aggregation and platelet dense granule release • Inhibits adenylate cyclase so drop in cAMP levels
63
Which granules release ADP
Dense granules
64
Thrombin activates protease-activated receptors (PAR) on platelets
This leads to platelet activation and release of ADP, which amplifies this activation
65
Amplification loops:
• Dense granules release ADP, which causes further activation • Activation of GPIIb/IIIa also amplifies platelet activation
66
Platelet procoagulant activity:
activated platelets catalyse thrombin generation, creating an amplification loop that also links with coagulation (the production of fibrin) 1. Aminophospholipids maintained on inner layer phospholipid bilayer- asymmetry 2. Platelet activation eg thrombin activating PAR1 3. Ca2+ release from intracellular stores 4. Activates enzyme scramblase which flips translocase enzyme so aminophospholipids flip to outer surface 5. Allows promthrombin complex to be assembled 6. Catalysed thrombin production via prothrombinase • Inhibition of translocase and activation of scramblase leads to expression of aminophospholipids on the outer platelet membane, which allows assembly of prothrombinase complex and generation of thrombin
67
Additional platelet receptors
feed into these amplification loops eg release of thromboxane A2
68
Platelet activation causes:
• Shape change • Cross-linking of GPIIb/IIIa • Platelet aggregation
69
Fibrinolytic system
• A dynamic interaction between fibrinolytic and anti-fibrinolytic factors is designed to maintain homeostasis i.e. haemostasis without thrombosis • Stop blood clotting
70
Fibrinolytic pathway
tPA Plasminogen Plasmin Fibrin Fibrin-degradation products
71
Platelets and inflammation:
Platelets have pro-inflammatory and prothrombotic interactions with leukocytes and release inflammatory mediators from alpha granules
72
Platelets and inflammation: monocytes
Cytokines e.g. chemotactic molecules Proteolytic Enzymes Pro-thrombotic molecules : Tissue factor Adhesion Molecules e.g. PSGL-1
73
Platelets and inflammation: alpha granules
Inflammatory mediators (vWF, thromboxane A2) Adhesion Molecules e.g. P-Selectin binds to PSGL-1 on monocytes (pro-inflammatory) Coagulation Factors (fibrinogen)
74
Platelet alpha granules
Mediate expression of surface P-selection and release of inflammatory mediators
75
Overview: platelet aggregation
• Mediated by GPIIb/IIIa activation (final common pathway) • Cross linking of platelets by fibrinogen
76
Overview:platelet adhesion
• Collagen and VWF exposed • Mediated by GPIb, alpha2beta1 and GPVI
77
Overview: platelet granules
• Mediators of vessel response to injury • Inflammatory mediators released from a granules
78
Overview: Thrombin → Coagulation cascade:
• Activated platelets support thrombin generation • Inhibited by anticoagulant drugs
79
Inhibitor of thromboxane A2 amplification pathway
Aspirin
80
Inhibitors of P2Y12 amplification pathway
Clopidogrel, Prasugrel, Ticagrelor
81
Percentage of blood made up of erythrocytes
43%
82
Percentage of blood made up of white blood cells
1%
83
Eosinophil structure
Bilobed nucleus IgE receptors Stain orange Granulocyte
84
Neutrophil granules
1’- lysosomes- myeloperoxidase and acid hydrolases 2’- inflammatory mediators 3’- gelatinases and adhesion molecules
85
Where are Kupffer cells found
Liver
86
Where are microglia macrophages found
CNS
87
Monocyte structure
Reuniform nucleus Agranulocytes but have granules
88
Lifespan of erythrocytes
120 days
89
Sites of erythropoesis
In utero- yolk sac ——> liver and spleen Children - all bones Adults - REFS (ribs, ends of long bones, flat bones of skull and pelvis, spine)
90
Where are RBCs destroyed
Liver, bone marrow and spleen
91
Where is erythropoietin made
Kidney
92
HbA
2 alpha chains 2 beta chains
93
HbF
2 alpha chains 2 gamma chains
94
HbA2
2 alpha chains 2 delta chains (delta = disease)
95
Thalassemia
Congenital mutations of alpha or beta chains
96
Thrombopoesis
Megakaryocytes ——> endomitosis - chromosomes duplicate without cell division ——> membrane blebbing
97
Where is thrombopoeitin produced
Liver and kidneys
98
Activation shape change
Smooth discoid ——> spiculated with pseudopodia (increased surface area)
99
Haemophilia
Inability to make clotting factors Type A = factor 8 deficiency Type B = factor 9 deficiency
100
Thrombocytopenia
Platelet deficiency Decreased production, increased destruction and altered redistribution
101
Pseudothrombocytopenia
Platelet clumping
102
Primary haemostats is
1. Injury- vasoconstriction via endothelin release 2. adhesion- exposed collagen —> vWF —> GP1b —>platelet 3. Activation- pseudopodia and granule release 4. Aggregation- platelet-GP2b/3a-fibrinogenGP2b/3a-platelet
103
Vitamin K dependant factors
10, 9, 7, 2
104
Virchow’s triad
Circulatory stasis + endothelial injury + hypercoaguable state = thrombosis
105
Overview of coagulation cascade
Intrinsic: 12 —> 11 —> 9 —> 8 —> 10 Extrinsic: 3 (tissue factor) + 7a —> 10 Common: 10 —> 5 —> 2- thrombin (from prothrombin) —> 1- fibrinogen —> fibrin mesh
106
Degradation of fibrin
Plasminogen —> plasmin Due to 7a (intrinsic) and endothelium —> tPA (extrinsic)
107
What are required for factor 9a and 10a function
Phospholipids Ca2+ Factor 5
108
+ve feedback: thrombin and phospholipids bilayer
Thrombin —> PAR1 or PAR4 receptors—> influx of Ca2+ 1. Blocks translocase 2. Activates scramblase Aminophospholipid expression on outer platelet membrane Prothrombinase complex assembly Prothrombin ——> thrombin
109
Low dose aspirin
Inhibits COX1 so less thromboxane A2—> less activation/aggregation
110
High dose aspirin
Inhibits COX1 and COX2 Reduction in aggregation mediated by platelets and inhibition of prostacyclin mediated inhibition, which means more aggregation
111
Malabsorption of what substance is most likely to cause excessive bruising and recurrent nosebleeds
Micelles- contain fat-soluble vitamins (ie vitamin K) which is essential for formation of Factor VII, IX, X and prothrombin Deficiency of vitamin K= excessive bleeding due to reduced clotting factors
112
Role of factor VIII
Converts the loose fibrin meshwork into a more stable network to allow entrapment of red blood cells (now the clot can begin to form)
113
Which clotting factors are vitamin K dependent
Factor II, VII, IX, X
114
The gene coding for alpha subunits of haemoglobin is found on which chromosome
16
115
What is tested for when diagnosing pernicious anaemia
Anti-intrinsic factor antibodies
116
When someone starts to bleed, a platelet plug begins to form. This is due to the coagulation cascade, where a series of factors combine and catalyse to eventually form a stable fibrin clot. One of these coagulation factors is thrombin. Which of the following processes shows the formation of thrombin in the cascade?
Xa + Va catalyse II → IIa

CVR (22 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2025 Bold Learning Solutions. Terms and Conditions